Validation of EuroSCORE II in Patients Undergoing Coronary Artery Bypass Surgery

Background The European System for Cardiac Operative Risk Evaluation II (EuroSCORE II) has been recently developed to improve the performance of the original EuroSCORE. Herein we evaluated its discriminatory ability in predicting the immediate and late outcome after coronary artery bypass grafting (...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Annals of thoracic surgery 2012-06, Vol.93 (6), p.1930-1935
Hauptverfasser: Biancari, Fausto, MD, PhD, Vasques, Francesco, MS, Mikkola, Reija, MS, Martin, Marta, MS, Lahtinen, Jarmo, MD, PhD, Heikkinen, Jouni, MD, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1935
container_issue 6
container_start_page 1930
container_title The Annals of thoracic surgery
container_volume 93
creator Biancari, Fausto, MD, PhD
Vasques, Francesco, MS
Mikkola, Reija, MS
Martin, Marta, MS
Lahtinen, Jarmo, MD, PhD
Heikkinen, Jouni, MD, PhD
description Background The European System for Cardiac Operative Risk Evaluation II (EuroSCORE II) has been recently developed to improve the performance of the original EuroSCORE. Herein we evaluated its discriminatory ability in predicting the immediate and late outcome after coronary artery bypass grafting (CABG). Methods Complete data on 1,027 patients who underwent isolated CABG were available for validation of EuroSCORE II and to compare its discriminatory ability with the original EuroSCORE and its Finnish modified version. Results EuroSCORE II performed somewhat better (area under the curve [AUC] 0.852, Brier score 0.031) than the original logistic EuroSCORE (AUC 0.838, Brier score 0.034) and its Finnish modified version (AUC 0.825, Brier score 0.034) in predicting operative mortality. The overall expected-to-observed operative mortality ratio for the original logistic EuroSCORE was 1.8, for its Finnish modified version was 0.6, and for EuroSCORE II was 1.2. EuroSCORE II showed expected-to-observed ratios ranging from 1.05 to 1.17 in its highest third quintiles. The best cutoff of EuroSCORE II in predicting operative postoperative mortality was 10% (21.5% vs 1.6%, p < 0.0001; sensitivity 91.5%, specificity 60.5%, negative predictive value 98.4%, accuracy of 90.3%). The EuroSCORE II was predictive of de novo dialysis (AUC 0.805), prolonged use of inotropes (AUC 0.748), and intensive care unit stay 5 days or greater (AUC 0.793). The risk of late mortality significantly increased across increasing quintiles of EuroSCORE II ( p < 0.0001). Conclusions The EuroSCORE II performs better than its original version in predicting operative mortality and morbidity after isolated CABG. Its ability to predict 30-day mortality in high-risk patients is of particular importance. The EuroSCORE II is also a good predictor of late postoperative survival.
doi_str_mv 10.1016/j.athoracsur.2012.02.064
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1017614561</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0003497512004262</els_id><sourcerecordid>1017614561</sourcerecordid><originalsourceid>FETCH-LOGICAL-c525t-e1b84f5224cb5e5e9aef901830a01e5ecff39d13c6ead8256c11f1df9cdc586e3</originalsourceid><addsrcrecordid>eNqNkVGLEzEQx4MoXj39CpIXwZetSTZJd1-Eu1K9wsEd1vM1pNlJTd0mNdk96Ld3Snse-CQMDMP8_jPJfwihnE054_rTdmqHnylbV8Y8FYyLKcPQ8gWZcKVEpYVqX5IJY6yuZDtTF-RNKVssBbZfkwshFNdNLSfk_oftQ2eHkCJNni7GnFbzu28LulzSEOk9diAOhT7EDvImhbih85RTtPlAr_IAmK4Pe1sKXY15g-Vb8srbvsC7c74kD18W3-c31e3d1-X86rZySqihAr5upFdCSLdWoKC14FvGm5pZxrF23tdtx2unwXaNUNpx7nnnW9c51WioL8nH09x9Tr9HKIPZheKg722ENBaDPs00l0pzRJsT6nIqJYM3-xx2-AOEjpw2W_Pspzn6aRiGlih9f94yrnfQ_RU-GYjAhzNgi7O9zza6UJ451UpZqxly1ycO0JPHANkUh8466EIGN5guhf95zed_hrg-xIB7f8EByjaNOaLnhpuCArM63v94fi4Yk0KL-g__cK3P</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1017614561</pqid></control><display><type>article</type><title>Validation of EuroSCORE II in Patients Undergoing Coronary Artery Bypass Surgery</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Biancari, Fausto, MD, PhD ; Vasques, Francesco, MS ; Mikkola, Reija, MS ; Martin, Marta, MS ; Lahtinen, Jarmo, MD, PhD ; Heikkinen, Jouni, MD, PhD</creator><creatorcontrib>Biancari, Fausto, MD, PhD ; Vasques, Francesco, MS ; Mikkola, Reija, MS ; Martin, Marta, MS ; Lahtinen, Jarmo, MD, PhD ; Heikkinen, Jouni, MD, PhD</creatorcontrib><description>Background The European System for Cardiac Operative Risk Evaluation II (EuroSCORE II) has been recently developed to improve the performance of the original EuroSCORE. Herein we evaluated its discriminatory ability in predicting the immediate and late outcome after coronary artery bypass grafting (CABG). Methods Complete data on 1,027 patients who underwent isolated CABG were available for validation of EuroSCORE II and to compare its discriminatory ability with the original EuroSCORE and its Finnish modified version. Results EuroSCORE II performed somewhat better (area under the curve [AUC] 0.852, Brier score 0.031) than the original logistic EuroSCORE (AUC 0.838, Brier score 0.034) and its Finnish modified version (AUC 0.825, Brier score 0.034) in predicting operative mortality. The overall expected-to-observed operative mortality ratio for the original logistic EuroSCORE was 1.8, for its Finnish modified version was 0.6, and for EuroSCORE II was 1.2. EuroSCORE II showed expected-to-observed ratios ranging from 1.05 to 1.17 in its highest third quintiles. The best cutoff of EuroSCORE II in predicting operative postoperative mortality was 10% (21.5% vs 1.6%, p &lt; 0.0001; sensitivity 91.5%, specificity 60.5%, negative predictive value 98.4%, accuracy of 90.3%). The EuroSCORE II was predictive of de novo dialysis (AUC 0.805), prolonged use of inotropes (AUC 0.748), and intensive care unit stay 5 days or greater (AUC 0.793). The risk of late mortality significantly increased across increasing quintiles of EuroSCORE II ( p &lt; 0.0001). Conclusions The EuroSCORE II performs better than its original version in predicting operative mortality and morbidity after isolated CABG. Its ability to predict 30-day mortality in high-risk patients is of particular importance. The EuroSCORE II is also a good predictor of late postoperative survival.</description><identifier>ISSN: 0003-4975</identifier><identifier>EISSN: 1552-6259</identifier><identifier>DOI: 10.1016/j.athoracsur.2012.02.064</identifier><identifier>PMID: 22516834</identifier><identifier>CODEN: ATHSAK</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Aged ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Area Under Curve ; Biological and medical sciences ; Cardiology. Vascular system ; Cardiothoracic Surgery ; Cause of Death ; Coronary Artery Bypass - statistics &amp; numerical data ; Coronary Artery Bypass, Off-Pump - statistics &amp; numerical data ; Coronary heart disease ; Female ; Finland ; Heart ; Heart Arrest, Induced ; Hospital Mortality ; Humans ; Kaplan-Meier Estimate ; Logistic Models ; Male ; Medical sciences ; Middle Aged ; Pneumology ; Postoperative Complications - mortality ; Prognosis ; Propensity Score ; Reproducibility of Results ; Surgery ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the heart</subject><ispartof>The Annals of thoracic surgery, 2012-06, Vol.93 (6), p.1930-1935</ispartof><rights>The Society of Thoracic Surgeons</rights><rights>2012 The Society of Thoracic Surgeons</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2012 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c525t-e1b84f5224cb5e5e9aef901830a01e5ecff39d13c6ead8256c11f1df9cdc586e3</citedby><cites>FETCH-LOGICAL-c525t-e1b84f5224cb5e5e9aef901830a01e5ecff39d13c6ead8256c11f1df9cdc586e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=25944357$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22516834$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Biancari, Fausto, MD, PhD</creatorcontrib><creatorcontrib>Vasques, Francesco, MS</creatorcontrib><creatorcontrib>Mikkola, Reija, MS</creatorcontrib><creatorcontrib>Martin, Marta, MS</creatorcontrib><creatorcontrib>Lahtinen, Jarmo, MD, PhD</creatorcontrib><creatorcontrib>Heikkinen, Jouni, MD, PhD</creatorcontrib><title>Validation of EuroSCORE II in Patients Undergoing Coronary Artery Bypass Surgery</title><title>The Annals of thoracic surgery</title><addtitle>Ann Thorac Surg</addtitle><description>Background The European System for Cardiac Operative Risk Evaluation II (EuroSCORE II) has been recently developed to improve the performance of the original EuroSCORE. Herein we evaluated its discriminatory ability in predicting the immediate and late outcome after coronary artery bypass grafting (CABG). Methods Complete data on 1,027 patients who underwent isolated CABG were available for validation of EuroSCORE II and to compare its discriminatory ability with the original EuroSCORE and its Finnish modified version. Results EuroSCORE II performed somewhat better (area under the curve [AUC] 0.852, Brier score 0.031) than the original logistic EuroSCORE (AUC 0.838, Brier score 0.034) and its Finnish modified version (AUC 0.825, Brier score 0.034) in predicting operative mortality. The overall expected-to-observed operative mortality ratio for the original logistic EuroSCORE was 1.8, for its Finnish modified version was 0.6, and for EuroSCORE II was 1.2. EuroSCORE II showed expected-to-observed ratios ranging from 1.05 to 1.17 in its highest third quintiles. The best cutoff of EuroSCORE II in predicting operative postoperative mortality was 10% (21.5% vs 1.6%, p &lt; 0.0001; sensitivity 91.5%, specificity 60.5%, negative predictive value 98.4%, accuracy of 90.3%). The EuroSCORE II was predictive of de novo dialysis (AUC 0.805), prolonged use of inotropes (AUC 0.748), and intensive care unit stay 5 days or greater (AUC 0.793). The risk of late mortality significantly increased across increasing quintiles of EuroSCORE II ( p &lt; 0.0001). Conclusions The EuroSCORE II performs better than its original version in predicting operative mortality and morbidity after isolated CABG. Its ability to predict 30-day mortality in high-risk patients is of particular importance. The EuroSCORE II is also a good predictor of late postoperative survival.</description><subject>Aged</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Area Under Curve</subject><subject>Biological and medical sciences</subject><subject>Cardiology. Vascular system</subject><subject>Cardiothoracic Surgery</subject><subject>Cause of Death</subject><subject>Coronary Artery Bypass - statistics &amp; numerical data</subject><subject>Coronary Artery Bypass, Off-Pump - statistics &amp; numerical data</subject><subject>Coronary heart disease</subject><subject>Female</subject><subject>Finland</subject><subject>Heart</subject><subject>Heart Arrest, Induced</subject><subject>Hospital Mortality</subject><subject>Humans</subject><subject>Kaplan-Meier Estimate</subject><subject>Logistic Models</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pneumology</subject><subject>Postoperative Complications - mortality</subject><subject>Prognosis</subject><subject>Propensity Score</subject><subject>Reproducibility of Results</subject><subject>Surgery</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the heart</subject><issn>0003-4975</issn><issn>1552-6259</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkVGLEzEQx4MoXj39CpIXwZetSTZJd1-Eu1K9wsEd1vM1pNlJTd0mNdk96Ld3Snse-CQMDMP8_jPJfwihnE054_rTdmqHnylbV8Y8FYyLKcPQ8gWZcKVEpYVqX5IJY6yuZDtTF-RNKVssBbZfkwshFNdNLSfk_oftQ2eHkCJNni7GnFbzu28LulzSEOk9diAOhT7EDvImhbih85RTtPlAr_IAmK4Pe1sKXY15g-Vb8srbvsC7c74kD18W3-c31e3d1-X86rZySqihAr5upFdCSLdWoKC14FvGm5pZxrF23tdtx2unwXaNUNpx7nnnW9c51WioL8nH09x9Tr9HKIPZheKg722ENBaDPs00l0pzRJsT6nIqJYM3-xx2-AOEjpw2W_Pspzn6aRiGlih9f94yrnfQ_RU-GYjAhzNgi7O9zza6UJ451UpZqxly1ycO0JPHANkUh8466EIGN5guhf95zed_hrg-xIB7f8EByjaNOaLnhpuCArM63v94fi4Yk0KL-g__cK3P</recordid><startdate>20120601</startdate><enddate>20120601</enddate><creator>Biancari, Fausto, MD, PhD</creator><creator>Vasques, Francesco, MS</creator><creator>Mikkola, Reija, MS</creator><creator>Martin, Marta, MS</creator><creator>Lahtinen, Jarmo, MD, PhD</creator><creator>Heikkinen, Jouni, MD, PhD</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120601</creationdate><title>Validation of EuroSCORE II in Patients Undergoing Coronary Artery Bypass Surgery</title><author>Biancari, Fausto, MD, PhD ; Vasques, Francesco, MS ; Mikkola, Reija, MS ; Martin, Marta, MS ; Lahtinen, Jarmo, MD, PhD ; Heikkinen, Jouni, MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c525t-e1b84f5224cb5e5e9aef901830a01e5ecff39d13c6ead8256c11f1df9cdc586e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Aged</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Area Under Curve</topic><topic>Biological and medical sciences</topic><topic>Cardiology. Vascular system</topic><topic>Cardiothoracic Surgery</topic><topic>Cause of Death</topic><topic>Coronary Artery Bypass - statistics &amp; numerical data</topic><topic>Coronary Artery Bypass, Off-Pump - statistics &amp; numerical data</topic><topic>Coronary heart disease</topic><topic>Female</topic><topic>Finland</topic><topic>Heart</topic><topic>Heart Arrest, Induced</topic><topic>Hospital Mortality</topic><topic>Humans</topic><topic>Kaplan-Meier Estimate</topic><topic>Logistic Models</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pneumology</topic><topic>Postoperative Complications - mortality</topic><topic>Prognosis</topic><topic>Propensity Score</topic><topic>Reproducibility of Results</topic><topic>Surgery</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the heart</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Biancari, Fausto, MD, PhD</creatorcontrib><creatorcontrib>Vasques, Francesco, MS</creatorcontrib><creatorcontrib>Mikkola, Reija, MS</creatorcontrib><creatorcontrib>Martin, Marta, MS</creatorcontrib><creatorcontrib>Lahtinen, Jarmo, MD, PhD</creatorcontrib><creatorcontrib>Heikkinen, Jouni, MD, PhD</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Annals of thoracic surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Biancari, Fausto, MD, PhD</au><au>Vasques, Francesco, MS</au><au>Mikkola, Reija, MS</au><au>Martin, Marta, MS</au><au>Lahtinen, Jarmo, MD, PhD</au><au>Heikkinen, Jouni, MD, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Validation of EuroSCORE II in Patients Undergoing Coronary Artery Bypass Surgery</atitle><jtitle>The Annals of thoracic surgery</jtitle><addtitle>Ann Thorac Surg</addtitle><date>2012-06-01</date><risdate>2012</risdate><volume>93</volume><issue>6</issue><spage>1930</spage><epage>1935</epage><pages>1930-1935</pages><issn>0003-4975</issn><eissn>1552-6259</eissn><coden>ATHSAK</coden><abstract>Background The European System for Cardiac Operative Risk Evaluation II (EuroSCORE II) has been recently developed to improve the performance of the original EuroSCORE. Herein we evaluated its discriminatory ability in predicting the immediate and late outcome after coronary artery bypass grafting (CABG). Methods Complete data on 1,027 patients who underwent isolated CABG were available for validation of EuroSCORE II and to compare its discriminatory ability with the original EuroSCORE and its Finnish modified version. Results EuroSCORE II performed somewhat better (area under the curve [AUC] 0.852, Brier score 0.031) than the original logistic EuroSCORE (AUC 0.838, Brier score 0.034) and its Finnish modified version (AUC 0.825, Brier score 0.034) in predicting operative mortality. The overall expected-to-observed operative mortality ratio for the original logistic EuroSCORE was 1.8, for its Finnish modified version was 0.6, and for EuroSCORE II was 1.2. EuroSCORE II showed expected-to-observed ratios ranging from 1.05 to 1.17 in its highest third quintiles. The best cutoff of EuroSCORE II in predicting operative postoperative mortality was 10% (21.5% vs 1.6%, p &lt; 0.0001; sensitivity 91.5%, specificity 60.5%, negative predictive value 98.4%, accuracy of 90.3%). The EuroSCORE II was predictive of de novo dialysis (AUC 0.805), prolonged use of inotropes (AUC 0.748), and intensive care unit stay 5 days or greater (AUC 0.793). The risk of late mortality significantly increased across increasing quintiles of EuroSCORE II ( p &lt; 0.0001). Conclusions The EuroSCORE II performs better than its original version in predicting operative mortality and morbidity after isolated CABG. Its ability to predict 30-day mortality in high-risk patients is of particular importance. The EuroSCORE II is also a good predictor of late postoperative survival.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>22516834</pmid><doi>10.1016/j.athoracsur.2012.02.064</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0003-4975
ispartof The Annals of thoracic surgery, 2012-06, Vol.93 (6), p.1930-1935
issn 0003-4975
1552-6259
language eng
recordid cdi_proquest_miscellaneous_1017614561
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Aged
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Area Under Curve
Biological and medical sciences
Cardiology. Vascular system
Cardiothoracic Surgery
Cause of Death
Coronary Artery Bypass - statistics & numerical data
Coronary Artery Bypass, Off-Pump - statistics & numerical data
Coronary heart disease
Female
Finland
Heart
Heart Arrest, Induced
Hospital Mortality
Humans
Kaplan-Meier Estimate
Logistic Models
Male
Medical sciences
Middle Aged
Pneumology
Postoperative Complications - mortality
Prognosis
Propensity Score
Reproducibility of Results
Surgery
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the heart
title Validation of EuroSCORE II in Patients Undergoing Coronary Artery Bypass Surgery
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T19%3A10%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Validation%20of%20EuroSCORE%20II%20in%20Patients%20Undergoing%20Coronary%20Artery%20Bypass%20Surgery&rft.jtitle=The%20Annals%20of%20thoracic%20surgery&rft.au=Biancari,%20Fausto,%20MD,%20PhD&rft.date=2012-06-01&rft.volume=93&rft.issue=6&rft.spage=1930&rft.epage=1935&rft.pages=1930-1935&rft.issn=0003-4975&rft.eissn=1552-6259&rft.coden=ATHSAK&rft_id=info:doi/10.1016/j.athoracsur.2012.02.064&rft_dat=%3Cproquest_cross%3E1017614561%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1017614561&rft_id=info:pmid/22516834&rft_els_id=S0003497512004262&rfr_iscdi=true